Goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. In addition, goserelin implant is used to treat certain benign gynecological disorders. The administration form is under a biodegradable implant that releases the active ingredient over a period of either one (3,6 mg dosage) or three (10.8 mg dosage) months. Goserelin is the only generic of the originator with global availability.